{"symbol": "FATE", "companyName": "Fate Therapeutics Inc.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.fatetherapeutics.com", "description": "Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.", "CEO": "J. Scott Wolchko", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}